EXPRESSION OF ER, PR AND HER2/neu IMMUNOMARKERS IN INFILTRATING DUCT CARCINOMA BREAST IN CELL BLOCK PREPARATIONS AS COMPARED TO HISTOPATHOLOGY

Journal of Evolution of Medical and Dental Sciences
doi 10.14260/jemds/2018/794
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Akshantala Enterprises Private Limited

Related search

A Study on the Role of Receptor (ER,PR,HER-2/neu) in Patients of Carcinoma Breast

International Journal Of Medical Science And Clinical Invention
2017English

Study on Histopathological Correlation With ER, PR, and HER 2 Neu Receptor Status in Breast Carcinoma and Its Prognostic Importance

SSR Institute of International Journal of Life Sciences
2019English

Correlation Between FOXP1 and ER/PR Expression in Endometrial Carcinoma

Oncotarget
Oncology
2017English

Immunohistochemical Expression of ER-α and PR in Papillary Thyroid Carcinoma

ecancermedicalscience
Cancer ResearchOncology
2017English

Study of Her2/Neu Expression in 100 Cases of Uterine and Cervical Carcinoma as a Prognostic Marker

Annals of Pathology and Laboratory Medicine
2018English

HER2/neu and Ki-67 Expression Predict Non-Invasive Recurrence Following Breast-Conserving Therapy for Ductal Carcinoma in Situ

British Journal of Cancer
Cancer ResearchOncology
2012English

Her2/Neu Protein Expression in Colorectal Cancer

Journal of Evolution of Medical and Dental Sciences
2019English

HER2/neu Antisense Therapeutics in Human Breast Cancer

2002English

The Role of HER2/neu Overexpression/Amplification in the Progression of Ductal Carcinoma in Situ to Invasive Carcinoma of the Breast

Modern Pathology
Forensic MedicinePathology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy